Effects of vaping cannabidiol products on lung health
Health effects of cannabidiol vaping products
This study is looking at how vaping products with CBD and other cannabinoids might impact lung health, especially by checking if harmful substances are created when these products are used, and it’s for anyone who vapes or is curious about the effects of vaping on their lungs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11042195 on NIH RePORTER |
What this research studies
This research investigates how vaping products containing cannabinoids, particularly cannabidiol (CBD) and its derivatives, affect lung health. It focuses on the chemical reactions that occur when these products are vaped, including the potential formation of harmful oxidation products due to the presence of metals and flavoring agents. By examining the toxicity of these products on airway epithelial cells, the study aims to understand the risks associated with vaping cannabinoids. Patients may be asked to provide information about their vaping habits and health to contribute to this important research.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who currently use or have used cannabinoid vaping products.
Not a fit: Patients who do not use cannabinoid vaping products or have never been exposed to such products may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a better understanding of the health risks associated with vaping cannabinoid products, potentially informing safer usage guidelines.
How similar studies have performed: While there is ongoing research into the health effects of vaping, this specific investigation into cannabinoid vaping products and their oxidation products is relatively novel.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Rebuli, Meghan Elizabeth — Univ of North Carolina Chapel Hill
- Study coordinator: Rebuli, Meghan Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.